Pacira BioSciences (PCRX) Debt Ratio (2010 - 2026)

Pacira BioSciences' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.3 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 59.0% year-over-year to 0.3 in Q1 2026; TTM through Mar 2026 was 0.3, a 59.0% increase from a year earlier, with the FY2025 full-year figure at 0.29, down 41.93% from the prior year.
• Debt Ratio grew to 0.3 in Q1 2026 per PCRX's latest filing, from 0.29 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.51 in Q4 2024 and bottomed at 0.07 in Q2 2024.
• The 5-year median for Debt Ratio is 0.2 (2025), against an average of 0.22.
• Across the five-year window, Debt Ratio plunged 56.97% in 2023 and jumped 193.05% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.43 in 2022, then retreated by 21.57% to 0.34 in 2023, then jumped by 50.2% to 0.51 in 2024, then sank by 41.93% to 0.29 in 2025, then increased by 3.39% to 0.3 in 2026.
• Per Business Quant, the three latest PCRX Debt Ratio figures stand at 0.3 (Q1 2026), 0.29 (Q4 2025), and 0.29 (Q3 2025).